Understanding iDose® TR: A Breakthrough in Glaucoma Treatment thumbnail

Understanding iDose® TR: A Breakthrough in Glaucoma Treatment

Published Nov 16, 24
1 min read


iDose® TR is a game-changing innovation in the treatment of glaucoma, providing a consistent and reliable option for managing intraocular pressure (IOP). Differing from traditional eye drops that require daily administration, iDose® TR is a compact, implantable device designed to deliver a controlled release of medication directly into the eye over an extended period. This groundbreaking approach reduces the burden of constant dosing, significantly improving patient adherence and overall treatment outcomes.

At Eye Center South, we are honored to introduce iDose® TR as part of our comprehensive glaucoma care. The device is implanted during a gentle procedure, designed with your ease in mind. Once in place, it delivers a steady release of glaucoma medication, keeping IOP levels consistent and ensuring your visual health. Patients who find challenges in the routine of applying eye drops daily can benefit greatly from this next-generation treatment.



Visit for more info At Eye Center South

Latest Posts

Contact Us

Published Nov 23, 24
1 min read

Innovative Collaborations in Design

Published Nov 23, 24
1 min read